November 7-10, 2010
Baltimore, MD
Booth #108

- Safety and Immunogenicity of Seasonal Influenza Trivalent VLP vaccine in New Zealand White Rabbits
- Safety and Immunogenicity of an Intranasal Anthrax Vaccine in New Zealand White Rabbits

- Safety and Immunogenicity Of Measles Vaccine, Dry Powder In Rhesus Monkeys

Presentation Location: Grand Ballroom V-X

September 20 - 23, 2010
Boston, MA
Booth #348

April 13, 2010 from 8:00 to 11:30 AM
Bethesda North Marriott Hotel and Conference Center

5701 Marinelli Drive, North Bethesda, MD 20852
Booth #108

March 7-11, 2010
Salt Lake City, Utah
Booth #416

Safety and Immunogenicity of an Inhaled Dry-Powder Measles Vaccine

Session Title: Regulation/Policy and Safety Assessment II
Presentation Date & Time: Wednesday, March 10, 2010 from 9:00 AM to 12:30 PM
Presentation Location: Exhibit Hall

The Effect of TA1 Alpha 1 as an Enhancer of Antibody Formation in Influenza-Vaccinated CD-1 Mice

Session Title: Alternatives and Animal Models II
Presentation Date & Time: Thursday, March 11, 2010 from 8:30 AM to 12:00 PM
Presentation Location: Exhibit Hall E (Convention Center)

TV-1380 (Albumin-Fused Mutated BChE) Attenuates the Cardiovascular and Respiratory Effects Induced by Cocaine in Cynomolgus Monkeys

Session Title: Cardiovascular and Cardiopulmonary Toxicology
Presentation Date & Time: Thursday, March 11, 2010 from 8:30 AM to 12:00 PM
Presentation Location: Exhibit Hall E (Convention Center)